• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人肝微粒体中UDP-葡萄糖醛酸基转移酶活性的研究。

Studies of UDP-glucuronyltransferase activities in human liver microsomes.

作者信息

Bock K W, Lilienblum W, von Bahr C

出版信息

Drug Metab Dispos. 1984 Jan-Feb;12(1):93-7.

PMID:6141920
Abstract

Human liver samples from a "liver bank" which have been previously characterized by the ability to catalyze cytochrome P-450 dependent reactions were analyzed for various UDP-glucuronyltransferase activities. When stored at -80 degrees C, UDP-glucuronyltransferase activities and latency characteristics of the enzyme appeared to be stable for up to 2 years. The correlation of UDP-glucuronyltransferase activity (4-methylumbelliferone as substrate) with enzyme activities towards 4-nitrophenol and 1-naphthol was much higher (r greater than 0.8) than that (r less than 0.3) observed with other enzyme activities (4-hydroxybiphenyl, morphine, and chloramphenicol as substrates), suggesting the presence of multiple enzyme forms in human liver. Livers of three patients treated with phenytoin or pentobarbital showed significantly higher UDP-glucuronyltransferase activities towards 1-naphthol, 4-methylumbelliferone, and bilirubin than those from five patients who did not receive these inducing agents.

摘要

对一个“肝脏库”中先前已通过催化细胞色素P - 450依赖性反应的能力进行表征的人类肝脏样本,分析了其各种UDP - 葡萄糖醛酸基转移酶活性。当保存在-80℃时,UDP - 葡萄糖醛酸基转移酶活性和该酶的潜伏特性在长达2年的时间内似乎都是稳定的。以4 - 甲基伞形酮为底物时UDP - 葡萄糖醛酸基转移酶活性与对4 - 硝基苯酚和1 - 萘酚的酶活性之间的相关性(r大于0.8)远高于以其他酶活性(以4 - 羟基联苯、吗啡和氯霉素为底物)观察到的相关性(r小于0.3),这表明人类肝脏中存在多种酶形式。三名接受苯妥英或戊巴比妥治疗的患者的肝脏对1 - 萘酚、4 - 甲基伞形酮和胆红素的UDP - 葡萄糖醛酸基转移酶活性明显高于五名未接受这些诱导剂的患者的肝脏。

相似文献

1
Studies of UDP-glucuronyltransferase activities in human liver microsomes.人肝微粒体中UDP-葡萄糖醛酸基转移酶活性的研究。
Drug Metab Dispos. 1984 Jan-Feb;12(1):93-7.
2
On the functional heterogeneity of UDP-glucuronyl transferase of mouse liver microsomes.小鼠肝脏微粒体UDP-葡萄糖醛酸转移酶的功能异质性
Res Commun Chem Pathol Pharmacol. 1982 Feb;35(2):291-302.
3
Differential induction of human liver UDP-glucuronosyltransferase activities by phenobarbital-type inducers.
Biochem Pharmacol. 1987 Dec 1;36(23):4137-43. doi: 10.1016/0006-2952(87)90572-7.
4
Purification of rat-liver microsomal UDP-glucuronyltransferase. Separation of two enzyme forms inducible by 3-methylcholanthrene or phenobarbital.大鼠肝脏微粒体UDP-葡萄糖醛酸基转移酶的纯化。两种可被3-甲基胆蒽或苯巴比妥诱导的酶形式的分离。
Eur J Biochem. 1979 Jul;98(1):19-26. doi: 10.1111/j.1432-1033.1979.tb13155.x.
5
Purification and properties of a rat liver phenobarbital-inducible 4-hydroxybiphenyl UDP-glucuronosyltransferase.大鼠肝脏苯巴比妥诱导型4-羟基联苯UDP-葡萄糖醛酸基转移酶的纯化及性质
Mol Pharmacol. 1991 Jul;40(1):80-4.
6
Immunochemical comparison of UDP-glucuronyltransferase from Gunn- and Wistar-rat livers.冈恩大鼠和Wistar大鼠肝脏中UDP-葡萄糖醛酸基转移酶的免疫化学比较。
Biochem J. 1980 Oct 1;191(1):155-63. doi: 10.1042/bj1910155.
7
Purification of a phenobarbital-inducible morphine UDP-glucuronyltransferase isoform, absent from Gunn rat liver.
Arch Biochem Biophys. 1994 Dec;315(2):345-51. doi: 10.1006/abbi.1994.1510.
8
Characteristics of renal UDP-glucuronyltransferase.肾UDP-葡萄糖醛酸基转移酶的特性
Life Sci. 1984 Jul 9;35(2):145-53. doi: 10.1016/0024-3205(84)90133-4.
9
Purification and properties of 4-hydroxybiphenyl UDP-glucuronyltransferase from bovine liver microsomes.牛肝微粒体中4-羟基联苯UDP-葡萄糖醛酸基转移酶的纯化及性质
J Biochem. 1992 Nov;112(5):578-82. doi: 10.1093/oxfordjournals.jbchem.a123943.
10
A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids.一种在V79细胞中稳定表达的重组苯巴比妥诱导型大鼠肝脏UDP-葡萄糖醛酸基转移酶(UDP-葡萄糖醛酸基转移酶2B1)催化吗啡、酚类和羧酸的葡萄糖醛酸化反应。
Mol Pharmacol. 1994 Jan;45(1):42-50.

引用本文的文献

1
Developmental aspects of human hepatic drug glucuronidation in young children and adults.幼儿和成人肝脏药物葡萄糖醛酸化的发育方面
Gut. 2002 Feb;50(2):259-65. doi: 10.1136/gut.50.2.259.
2
Crigler-Najjar syndrome type II. New observation of possible autosomal recessive inheritance.克里格勒-纳贾尔综合征II型。常染色体隐性遗传可能性的新观察。
Dig Dis Sci. 1995 Jan;40(1):28-32. doi: 10.1007/BF02063937.
3
Induction of cytochrome P-448 iso-enzymes and related glucuronyltransferases in the human liver by cigarette smoking.
Eur J Clin Pharmacol. 1986;30(4):475-80. doi: 10.1007/BF00607963.
4
Paracetamol as a test drug to determine glucuronide formation in man. Effects of inducers and of smoking.对乙酰氨基酚作为一种测试药物用于确定人体中葡萄糖醛酸苷的形成。诱导剂和吸烟的影响。
Eur J Clin Pharmacol. 1987;31(6):677-83. doi: 10.1007/BF00541295.
5
Glucuronyl transferase deficiency and mild hereditary spherocytosis: effect of splenectomy.
Eur J Pediatr. 1988 Aug;147(6):639-42. doi: 10.1007/BF00442481.
6
Properties of human hepatic UDP-glucuronosyltransferases. Relationship to other inducible enzymes in patients with cholestasis.人肝脏UDP-葡萄糖醛酸基转移酶的特性。与胆汁淤积患者其他诱导酶的关系。
Eur J Clin Pharmacol. 1987;32(5):485-91. doi: 10.1007/BF00637675.
7
Investigation of the molecular basis of the genetic deficiency of UDP-glucuronosyltransferase in Crigler-Najjar syndrome.克里格勒-纳贾尔综合征中尿苷二磷酸葡萄糖醛酸基转移酶基因缺陷的分子基础研究。
J Inherit Metab Dis. 1991;14(4):563-79. doi: 10.1007/BF01797927.